BCL2 and lymphoma: Our results showed the coexpression of survivin and Bcl-2 positively correlated in the relapsed group and also in primary refractory DLBCL, which indicates an upregulation of anti-apoptotic and pro-survival mechanisms in the lymphoma cells.